Reference
Dos Santos G, et al. Brand-Specific Enhanced Safety Surveillance Study of GSK's Quadrivalent Seasonal Influenza Vaccine, Conducted During the COVID-19 Pandemic, in Belgium, Germany and Spain, for the 2020/21 Season Infectious Diseases and Therapy : 27 Dec 2021. Available from: URL: https://doi.org/10.1007/s40121-021-00571-y
Rights and permissions
About this article
Cite this article
No safety signals for GSK quadrivalent influenza vaccine. Reactions Weekly 1889, 7 (2022). https://doi.org/10.1007/s40278-022-08686-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-08686-z